07:01 AM EDT, 05/02/2024 (MT Newswires) -- Novo Nordisk ( NVO ) reported Q1 earnings Thursday of 5.68 Danish kroner ($0.81) per diluted American depositary receipt, up from 4.39 kroner a year earlier.

Analysts polled by Capital IQ expected 5.36 kroner.

Net sales for the quarter ended March 31 were 65.35 billion kroner, up from 53.37 billion a year earlier.

Analysts polled by Capital IQ expected 63.57 billion.

Shares of the company were down 2% in recent Thursday premarket activity.

Price: 126.42, Change: -2.79, Percent Change: -2.16